IDEXX Laboratories (HAM:IX1) Insider Ownership: 0.00 % (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:IX1 IDEXX Laboratories Inc HAM:IX1
96 GF Score
Price €489.00
GF Value €544.63
Valuation Modestly Undervalued
View Full Analysis

What is IDEXX Laboratories Insider Ownership?

IDEXX Laboratories HAM:IX1 -2.82% 96 Insider Ownership is 0.00 % as of Aug. 14, 2026. GuruFocus rates HAM:IX1 with a GF Score™ of 96/100 and a GF Value™ of €544.63 (Modestly Undervalued).

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, IDEXX Laboratories's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, IDEXX Laboratories's Institutional Ownership is 68.68%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, IDEXX Laboratories's Float Percentage Of Total Shares Outstanding is 87.46%.

IDEXX Laboratories Insider Ownership Historical Data

* Premium members only.

The historical data trend for IDEXX Laboratories's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories Insider Ownership Chart

IDEXX Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Insider Ownership
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IDEXX Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HAM:IX1
96GF Score
IDEXX Laboratories Inc HAM:IX1
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEXX Laboratories Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.00 % mean?
IDEXX Laboratories (HAM:IX1) has a Insider Ownership of 0.00 % as of Aug. 14, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on IDEXX Laboratories and its competitors.
Is IDEXX Laboratories' Insider Ownership too high?
IDEXX Laboratories' current Insider Ownership is 0.00 %. Overall, IDEXX Laboratories has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDEXX Laboratories' Insider Ownership compare to A and NTRA?
IDEXX Laboratories' Insider Ownership of 0.00 % can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Medical Diagnostics & Research company?
A good Insider Ownership depends on the Medical Diagnostics & Research industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on IDEXX Laboratories and its competitors. IDEXX Laboratories's current Insider Ownership is 0.00 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEXX Laboratories stock overvalued right now?
Based on GuruFocus' analysis, IDEXX Laboratories (HAM:IX1) is currently considered Modestly Undervalued. The stock's GF Value™ is €544.63, compared to a current price of €489.00 — trading 10.2% below its estimated fair value. The current Insider Ownership is 0.00 %. IDEXX Laboratories' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For IDEXX Laboratories (HAM:IX1), the current Insider Ownership is 0.00 % as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEXX Laboratories (HAM:IX1) Overvalued in 2026?

Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued. The current stock price of €489.00 is trading 10.2% below its estimated GF Value™ of €544.63. GuruFocus considers IDEXX Laboratories to be Modestly Undervalued.

Key valuation signals for HAM:IX1:

  • Insider Ownership: 0.00 %
  • GF Value™: €544.63 vs. price of €489.00 (10.2% below fair value)
  • GF Score™: 96/100

No single metric tells the full story. See the HAM:IX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDEXX Laboratories Business Description

Address One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
96GF Score

Get the complete analysis for HAM:IX1

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€489.00
Price
€544.63
GF Value